Co-Authors
This is a "connection" page, showing publications co-authored by Atsushi Okumura and Friederike Feldmann.
Connection Strength
1.070
-
Recovery from Acute SARS-CoV-2 Infection and Development of Anamnestic Immune Responses in T Cell-Depleted Rhesus Macaques. mBio. 2021 08 31; 12(4):e0150321.
Score: 0.060
-
Intradermal delivery of a synthetic DNA vaccine protects macaques from Middle East respiratory syndrome coronavirus. JCI Insight. 2021 05 24; 6(10).
Score: 0.059
-
Orally delivered MK-4482 inhibits SARS-CoV-2 replication in the Syrian hamster model. Nat Commun. 2021 04 16; 12(1):2295.
Score: 0.059
-
A single intranasal dose of chimpanzee adenovirus-vectored vaccine protects against SARS-CoV-2 infection in rhesus macaques. Cell Rep Med. 2021 04 20; 2(4):100230.
Score: 0.058
-
Publisher Correction: ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques. Nature. 2021 Feb; 590(7844):E24.
Score: 0.058
-
Single-cell RNA sequencing reveals SARS-CoV-2 infection dynamics in lungs of African green monkeys. Sci Transl Med. 2021 01 27; 13(578).
Score: 0.058
-
Hydroxychloroquine prophylaxis and treatment is ineffective in macaque and hamster SARS-CoV-2 disease models. JCI Insight. 2020 12 03; 5(23).
Score: 0.057
-
Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infection. Emerg Microbes Infect. 2020 Dec; 9(1):2673-2684.
Score: 0.057
-
ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques. Nature. 2020 10; 586(7830):578-582.
Score: 0.056
-
A single dose of ChAdOx1 MERS provides protective immunity in rhesus macaques. Sci Adv. 2020 06; 6(24):eaba8399.
Score: 0.055
-
Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2. Nature. 2020 09; 585(7824):273-276.
Score: 0.055
-
Respiratory disease in rhesus macaques inoculated with SARS-CoV-2. Nature. 2020 09; 585(7824):268-272.
Score: 0.055
-
Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection. Proc Natl Acad Sci U S A. 2020 03 24; 117(12):6771-6776.
Score: 0.054
-
Prophylactic and therapeutic efficacy of mAb treatment against MERS-CoV in common marmosets. Antiviral Res. 2018 08; 156:64-71.
Score: 0.048
-
Domestic Pig Unlikely Reservoir for MERS-CoV. Emerg Infect Dis. 2017 06; 23(6):985-988.
Score: 0.045
-
Efficacy of antibody-based therapies against Middle East respiratory syndrome coronavirus (MERS-CoV) in common marmosets. Antiviral Res. 2017 07; 143:30-37.
Score: 0.044
-
A Systems Approach Reveals MAVS Signaling in Myeloid Cells as Critical for Resistance to Ebola Virus in Murine Models of Infection. Cell Rep. 2017 01 17; 18(3):816-829.
Score: 0.044
-
A synthetic consensus anti-spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates. Sci Transl Med. 2015 Aug 19; 7(301):301ra132.
Score: 0.040
-
Infection with MERS-CoV causes lethal pneumonia in the common marmoset. PLoS Pathog. 2014 Aug; 10(8):e1004250.
Score: 0.037
-
Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques. Proc Natl Acad Sci U S A. 2013 Oct 08; 110(41):16598-603.
Score: 0.035
-
Treatment with interferon-a2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques. Nat Med. 2013 Oct; 19(10):1313-7.
Score: 0.035